Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- University of Minnesota
- THE UNIVERSITY OF HONG KONG
- University of Basel
- University of Kentucky
- Boehringer Ingelheim International GmbH
- Institut d’Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI-CERCA)
- Linköping University
- Maimonides Biomedical Research Institute of Cordoba - IMIBIC
- NEW YORK UNIVERSITY ABU DHABI
- SUNY University at Buffalo
- Stanford University
- University College Cork
- University of Colorado
- University of Liverpool
- University of North Carolina at Chapel Hill
- University of Washington
- Wageningen University & Research
- 7 more »
- « less
-
Field
-
Boehringer Ingelheim International GmbH | Biberach an der Ri, Baden W rttemberg | Germany | about 22 hours ago
of recommendation, on opnMe by October 21, 2026, 11:59 pm PST. Apply via: https://www.opnme.com/opn2talents/ah-02-cross-species-obesity?cid=af:nat-careers:o2tAH2:extredirect:joblist Rewards and Benefits As the
-
of Clinical Medicine, and the State Key Laboratory of Pharmaceutical Biotechnology Duties and Responsibilities Conduct research on chronic metabolic diseases, including obesity, diabetes, ageing, cardiovascular
-
metabolic diseases, including obesity, diabetes, ageing, cardiovascular diseases, metabolic dysfunction associated steatohepatitis (MASH), neurodegenerative disorders, and biostatistics Discover and
-
researching mechanisms and pathways of metabolic disease. Our goal is to leverage this understanding to identify novel therapeutic approaches that will address the unmet needs of patients affected by obesity
-
Non-obese diabetic (NOD) mouse handling, monitoring and husbandry skills including diabetes monitoring and management, biological/cellular imaging, and human tissues, PCR troubleshooting, Western blot
-
pave a path to clinical applications. This project is flanked by basic research projects i) investigating of the role of phosphoinositide 3-kinase (PI3K) signaling in allergy, metabolic control, obesity
-
aspire to be the leading research and education physiology program in the country. Our research vision is focused on mechanistic studies of the cardiovascular system, including muscle, and in obesity
-
Thesis based on ABIS. The main areas have so far been studies on the development of Type 1 diabetes, but also studies on celiac disease, JIA, IBD, autism, obesity, allergy and recently also psoriasis
-
Summary The Markey Cancer Center is seeking a Post-Doctoral Scholar. We have established the importance of neurotensin (NTS), a gut hormone peptide, in obese development and its associated metabolic
-
the Appetite & Obesity research group. The project is led by Professor Eric Robinson and Dr Amy Finlay, University of Liverpool. Project partners include Oxford University, London School of Hygiene and Tropical